Cambridge Investment Research Advisors, Inc. Journey Medical Corp Call Options Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DERM
# of Institutions
38Shares Held
3.15MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$5.02 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA310KShares$1.8 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny264KShares$1.53 Million0.0% of portfolio
-
American Financial Group Inc180KShares$1.04 Million0.44% of portfolio
-
Pvg Asset Management Corp Golden, CO159KShares$919,5323.82% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $67.3M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...